Alto Neuroscience, Inc.
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
ANRO | NYSE
Overview
Corporate Details
- ISIN(s):
- US02157Q1094
- LEI:
- Country:
- United States of America
- Address:
- 650 CASTRO STREET, SUITE 450, 94041 MOUNTAIN VIEW
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company dedicated to redefining psychiatry through a precision medicine approach. The company develops biology-driven medicines for neuropsychiatric conditions by leveraging its proprietary biomarker platform, which analyzes individual brain biology to predict patient response to treatment. This methodology aims to replace the traditional trial-and-error approach with personalized therapies. Alto's clinical-stage pipeline is initially focused on developing novel drug candidates for major depressive disorder, bipolar depression, and schizophrenia, with the goal of helping patients achieve better outcomes faster.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Alto Neuroscience, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alto Neuroscience, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alto Neuroscience, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
